Saturday, September 28, 2019 – 7:00 PM to 10:00 PM
at The Sleeping Octopus Historic Mansion
1300 Wood St., Pittsburgh, PA 15221
On Saturday, September 28, 2019, you’re invited to join MAPS for an intimate benefit dinner in a historic mansion with MAPS Founder Rick Doblin, Ph.D., and Shannon Clare Carlin, M.A., A.M.F.T., Director of Training and Supervision for MAPS’ MDMA Therapy Training Program. The dinner will feature special guest, neuroscientist Dr. Gül Dölen, M.D., Ph.D., of Johns Hopkins Medicine.
Space is very limited, so reserve your seat at the table today!
This gathering takes place during the second annual Sleeping Octopus Assembly on Psychedelics (SOAP) conference, happening in Pittsburgh, Pennsylvania, from September 27-29. SOAP is hosted in partnership with MAPS and the Pittsburgh Psychedelic Society.
$250 – Single Admission
$1500 – Patron Package – includes two dinner seats, and two passes to SOAP (3 available)
Shannon Clare Carlin, M.A., A.M.F.T.
Shannon Clare Carlin, M.A., A.M.F.T., is the Associate Director of Training and Supervision at the MAPS Public Benefit Corporation (MAPS PBC), a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) non-profit. As the Associate Director of Training and Supervision, Shannon oversees the development and implementation of the programs that provide training and supervision to prepare mental health and medical professionals to deliver MDMA-assisted psychotherapy in approved clinical settings.
In her dedication to supporting people through growth and healing, Shannon has served as a co-therapist on MAPS-sponsored Phase 2 trials researching MDMA-assisted psychotherapy for anxiety associated with life-threatening illness and MDMA-assisted psychotherapy for severe PTSD. Shannon’s direct clinical work continues to inform the development and implementation of the training programs she oversees.
Rick Doblin, Ph.D.
Rick Doblin, Ph.D., is Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary’s Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife, two dogs, and empty rooms from three children, one of whom is in college and two have graduated.
Dr. Gul Dölen, M.D., Ph.D.
Gül is an Assistant Professor in the Department of Neuroscience and Brain Science Institute, as well as the Director of Minority affairs. She received her graduate training at MIT and Brown University, in the laboratory of Dr. Mark Bear. She received postdoctoral training at Stanford University, in the laboratory of Dr. Rob Malenka. She joined the faculty at Johns Hopkins in 2014.
Dan Mottsman, Roddy Gibbs, Josh Knauer
Please send any questions to firstname.lastname@example.org
Thank you to Dr. Bronner’s for their company’s support of this event!